| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $279.6M | $274.1M | $311.6M |
| YoY Revenue Growth % | +2.0% | -12.0% | — |
| Gross Profit | $103.0M | $109.8M | — |
| Gross Margin % | 36.9% | 40.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$24.5M | -$41.7M | -$28.9M |
| Operating Margin % | -8.8% | -15.2% | -9.3% |
| Net Income (GAAP) | -$101.0M | -$115.1M | -$41.3M |
| EBITDA (Normalized) | -$23.1M | -$37.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$37.9M | -$23.6M | -$10.2M |
| Capital Expenditures (CapEx) | $1.7M | $4.9M | — |
| Free Cash Flow (FCF) | -$39.6M | -$28.6M | -$10.2M |
| FCF Margin % | -14.2% | -10.4% | -3.3% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $13.2M | $20.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$184.2M | -$196.6M | — |